Pdb94 - Initial Antidiabetic Pharmacotherapy Prescribed to Patients With Newly Diagnosed Type-2 Diabetes in a Commercial Health Plan in the United Stated

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.799
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Dynamic Thiol/Disulfide Homeostasis in Patients With Newly Diagnosed Type 2 Diabetes Mellitus

Endocrine Abstracts
2015English

The Role of Co-Morbidity in the Selection of Antidiabetic Pharmacotherapy in Type-2 Diabetes

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2013English

Predicting Chronic Comorbid Conditions of Type 2 Diabetes in Newly-Diagnosed Diabetic Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2015English

Diabetic Peripheral Neuropathy and Sudomotor Dysfunction in Saudi Patients With Newly Diagnosed Type 2 Diabetes Mellitus

Journal of Diabetes, Metabolic Disorders & Control
2017English

High Prevalence of the Metabolic Syndrome Among Newly Diagnosed Type 2 Diabetes Patients in Denmark

Endocrine Abstracts
2013English

The Level of Netrin-1 Is Decreased in Newly Diagnosed Type 2 Diabetes Mellitus Patients

BMC Endocrine Disorders
MedicineEndocrinologyMetabolismDiabetes
2016English

Organ-Specific Autoantibodies in Chinese Patients Newly Diagnosed With Type 1 Diabetes Mellitus

Endocrine Journal
EndocrinologyMetabolismDiabetes
2020English

Physician Reasons for Nonpharmacologic Treatment of Hyperglycemia in Older Patients Newly Diagnosed With Type 2 Diabetes Mellitus

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2012English

A Trial of Nicotinamide in Newly Diagnosed Patients With Type 1 (Insulin-Dependent) Diabetes Mellitus

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy